A2 Katsausartikkeli tieteellisessä aikausilehdessä
The forgotten tale of Brazilian phage therapy (2020)

de Freitas Almeida, G. M., & Sundberg, L.-R. (2020). The forgotten tale of Brazilian phage therapy. The Lancet Infectious Diseases, 20(5), e90-e101. https://doi.org/10.1016/S1473-3099(20)30060-8

JYU-tekijät tai -toimittajat

Julkaisun tiedot

Julkaisun kaikki tekijät tai toimittajat: de Freitas Almeida, Gabriel Magno; Sundberg, Lotta-Riina

Lehti tai sarja: The Lancet Infectious Diseases

ISSN: 1473-3099

eISSN: 1474-4457

Julkaisuvuosi: 2020

Volyymi: 20

Lehden numero: 5

Artikkelin sivunumerot: e90-e101

Kustantaja: Elsevier

Julkaisumaa: Britannia

Julkaisun kieli: englanti

DOI: https://doi.org/10.1016/S1473-3099(20)30060-8

Julkaisun avoin saatavuus: Ei avoin

Julkaisukanavan avoin saatavuus: 

Julkaisu on rinnakkaistallennettu (JYX): https://jyx.jyu.fi/handle/123456789/68812

Lisätietoja: Historical Review.

Tiivistelmä

The use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and missing pieces of phage therapy history. Of note, there is the widespread use of phages against bacillary dysentery and staphylococcal infections, with José da Costa Cruz from the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) as Brazil's leading expert and pioneer. This Historical Review about historical phage use in Brazil fills the gaps in our knowledge about the so-called golden years of phage therapy, providing information about successful experiences that can be useful against dangerous pathogens in our time.

YSO-asiasanat: bakteeritaudit; bakteriofagit; fagiterapia; oppihistoria; tutkimushistoria

Vapaat asiasanat: Brasilia

Liittyvät organisaatiot

Hankkeet, joissa julkaisu on tehty

OKM-raportointi: Kyllä

Raportointivuosi: 2020

JUFO-taso: 3